None
Quote | EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT)
Last: | $17.65 |
---|---|
Change Percent: | -0.97% |
Open: | $17.67 |
Close: | $17.65 |
High: | $17.8 |
Low: | $16.71 |
Volume: | 1,548,434 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
News | EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT)
2024-04-19 18:07:40 ET More on Ocular Therapeutix Ocular Therapeutix's Impressive Surge: A Strategic Insight Ocular Therapeutix: Diabetic Retinopathy Data Q2 2024 And Wet AMD Advancement Ocular marks early-stage trial win for diabetic retinopathy candidate Oc...
2024-04-18 10:00:26 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Short interest in S&P 500 health stocks rises, Moderna among m...
Message Board Posts | EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $EYPT News Article - EyePoint Pharmaceuticals Reports First Quarter 2023 Financial Resu | whytestocks | investorshangout | 05/03/2023 2:25:48 PM |
whytestocks: $EYPT News Article - EyePoint Pharmaceuticals to Report First Quarter 2023 Financial Re | whytestocks | investorshangout | 04/26/2023 12:10:49 PM |
znewcar1: $EYPT 58% v22,7M c9.00 f34,3M H10.41 S7.4 | znewcar1 | investorshangout | 04/22/2023 3:00:22 AM |
whytestocks: $EYPT News Article - EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) Near the Top of Equit | whytestocks | investorshangout | 04/21/2023 6:35:46 PM |
znewcar1: This hit a H in the video of 18 and yet the vol is different Not sure of the float then ye | znewcar1 | investorshangout | 04/21/2023 2:27:08 PM |
News, Short Squeeze, Breakout and More Instantly...
EyePoint Pharmaceuticals Inc. Company Name:
EYPT Stock Symbol:
NASDAQ Market:
EyePoint Pharmaceuticals Inc. Website:
2024-04-11 09:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
- Charles Wykoff, M.D., Ph.D. joins Carl Regillo, M.D., FACS as co-chair of Scientific Advisory Board – - Usha Chakravarthy, M.B.B.S, PhD., Alle...
- Charles Wykoff, M.D., Ph.D. joins Carl Regillo, M.D., FACS as co-chair of Scientific Advisory Board – - Usha Chakravarthy, M.B.B.S, PhD., Allen Ho, M.D. FACS FASRS and Frank Holz, M.D., F.E.B.O, F.A.R.V.O join in advance of global Phase 3 clinical trials for EYP-1901(DURAVYU) i...